The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
FDG PET of Infection and Inflammation
Abstract
Nuclear medicine plays an important role in the evaluation of infection and inflammation. Fluorine 18 fluorodeoxyglucose (FDG) is a readily available radiotracer that offers rapid, exquisitely sensitive high-resolution tomography. In patients with acquired immunodeficiency syndrome, FDG positron emission tomography (PET) accurately helps localize foci of infection and is particularly useful for differentiating central nervous system lymphoma from toxoplasmosis. FDG PET can also help localize the source of fever of undetermined origin (FUO), thereby guiding additional testing. In the musculoskeletal system, FDG PET accurately helps diagnose spinal osteomyelitis, and in inflammatory conditions such as sarcoidosis and vasculitis, it appears to be useful for defining the extent of disease and monitoring response to treatment. FDG PET may be of limited usefulness in postoperative patients and in patients with a failed joint prosthesis or a tumor. Nevertheless, this relatively new imaging technique promises to be helpful in the diagnosis of infection and inflammation. FDG PET will likely assume increasing importance in assessing FUO, spinal osteomyelitis, vasculitis, and sarcoidosis and may even become the radionuclide imaging procedure of choice in the evaluation of some or all of these pathologic conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed Central · doi:10.2967/jnumed.120.251744a · Cited by 1,172
Pitfalls in Oncologic Diagnosis with FDG PET Imaging: Physiologic and Benign Variants
Shreve, P. D., Anzai, Y., & Wahl, R. L. (1999) · RadioGraphics · doi:10.1148/radiographics.19.1.g99ja0761 · Cited by 827
Vertebral osteomyelitis: assessment using MR.
Modic, M. T., Feiglin, D., Piraino, D. W., Boumphrey, F., Weinstein, M. A., Duchesneau, P. M., & Rehm, S. J. (1985) · Radiology · doi:10.1148/radiology.157.1.3875878 · Cited by 772
Zasadny, K. R., & Wahl, R. L. (1993) · Radiology · doi:10.1148/radiology.189.3.8234714 · Cited by 635
Zhuang, H., & Alavi, A. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.29278 · Cited by 524
Structure and function of mammalian facilitative sugar transporters.
Bell, G. I., Burant, C. F., Takeda, J., & Gould, G. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36489-0 · Cited by 465
Cook, G. J. R., Fogelman, I., & Maisey, M. N. (1996) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(96)80006-7 · Cited by 381
YEUNG, H. W. D., Grewal, R. K., Gönen, M., Schöder, H. M., & Larson, S. M. (2003) · PubMed · Cited by 370
FDG Accumulation and Tumor Biology
Pauwels, E. K. J., Ribeiro, M. J., Stoot, J. H. M. B., McCready, V. R., Bourguignon, M., & Mazière, B. (1998) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(97)00226-6 · Cited by 366
Blockmans, D., Stroobants, S., Maes, A., & Mortelmans, L. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00424-6 · Cited by 347
Cited by
Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging
Jung, H. N., Lee, S.-Y., Lee, S., Youn, H., & Im, H.-J. (2022) · Theranostics · doi:10.7150/thno.77259 · Cited by 282
Assessing the interactions between radiotherapy and antitumour immunity
Grassberger, C., Ellsworth, S. G., Wilks, M. Q., Keane, F. K., & Loeffler, J. S. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0238-9 · Cited by 244
Nano-based theranostics for chronic obstructive lung diseases: challenges and therapeutic potential
Vij, N. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.597381 · Cited by 60
FDG PET/CT-based response assessment in malignancies
Parihar, A. S., Dehdashti, F., & Wahl, R. L. (2023) · RadioGraphics · doi:10.1148/rg.220122 · Cited by 53
“Apart from sites of physiologic biodistribution and their variants, FDG avidity is also seen in several nonneoplastic processes (4–8).”
Metadata
- Authors
- Love, C., Tomas, M. B., Tronco, G. G., & Palestro, C. J.
- Venue
- RadioGraphics
- Published
- 2005-09
- Volume
- 25
- Issue
- 5
- Pages
- 1357-1368
- ISSN
- 0271-5333 (ISSN-L)
- 1527-1323
- OpenAlex
- W2063884776
- Cited by
- 484
- References
- 35
- FWCI
- 15.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: FDG PET of Infection and Inflammation. https://app.cochat.ai/papers/10.1148/rg.255045122
- The paper
- Love, C., Tomas, M. B., Tronco, G. G., & Palestro, C. J. (2005). FDG PET of Infection and Inflammation. RadioGraphics. https://doi.org/10.1148/rg.255045122
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
